about
Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivoRole of Osteogenic Growth Peptide (OGP) and OGP(10-14) in Bone Regeneration: A ReviewEffects of the immobilization of heparin and rhPDGF-BB to titanium surfaces for the enhancement of osteoblastic functions and anti-inflammation.Immobilizing osteogenic growth peptide with and without fibronectin on a titanium surface: effects of loading methods on mesenchymal stem cell differentiationHow does the pathophysiological context influence delivery of bone growth factors?Cannabinoid receptors and the regulation of bone mass.Physical stability of arginine-glycine-aspartic acid peptide coated on anodized implants after installationCannabinoids and the skeleton: from marijuana to reversal of bone loss.Osteogenic growth peptide and its use as a bio-conjugate in regenerative medicine applications.Structure-activity relationships of the human prothrombin kringle-2 peptide derivative NSA9: anti-proliferative activity and cellular internalization.Multifunctional and Spatially Controlled Bioconjugation to Melt Coextruded Nanofibers.Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.Multilayered pore-closed PLGA microsphere delivering OGP and BMP-2 in sequential release patterns for the facilitation of BMSCs osteogenic differentiation.Characterization and in vitro evaluation of bacterial cellulose membranes functionalized with osteogenic growth peptide for bone tissue engineering.
P2860
Q24798502-433DCB18-1A0E-4F84-A9BA-48AEAD81628FQ28069731-110F244A-2A00-4F47-95EF-54D6E69DC624Q34067073-16DC3044-8623-40A4-B14D-7D2936676A99Q35049321-9B169D21-AF0C-4CBB-AB23-EB3A3B356081Q35463054-E7757F2A-E384-400C-B0F9-2B7CD6FBAB93Q36416382-4DC53AE3-9993-4A31-AF8A-A3ECA332B29AQ36909449-A538BA20-3AA3-49D1-A9CD-FDEC0719EC1BQ37563061-ABE9FBB5-D16F-4FDE-8BAE-7E834884CB69Q38590564-50EF4D8D-DE2E-4CC6-85A3-2A72DE3311C6Q40334510-B4A4ACE4-4F6B-4193-B036-5B4A27513D78Q42629640-2DF1511B-82DD-4616-98A1-6812154AF00AQ46029936-85850D79-3CD6-4DC1-B401-50A58DCAB16FQ47700878-FC3440E5-AC70-4748-A8EA-3684C73854A5Q51758876-1EA1BC30-D002-4881-AB1A-212C8F9CDBF5
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Osteogenic growth peptide: from concept to drug design.
@ast
Osteogenic growth peptide: from concept to drug design.
@en
Osteogenic growth peptide: from concept to drug design.
@nl
type
label
Osteogenic growth peptide: from concept to drug design.
@ast
Osteogenic growth peptide: from concept to drug design.
@en
Osteogenic growth peptide: from concept to drug design.
@nl
prefLabel
Osteogenic growth peptide: from concept to drug design.
@ast
Osteogenic growth peptide: from concept to drug design.
@en
Osteogenic growth peptide: from concept to drug design.
@nl
P2860
P356
P1433
P1476
Osteogenic growth peptide: from concept to drug design.
@en
P2093
Michael Chorev
P2860
P356
10.1002/BIP.10202
P577
2002-01-01T00:00:00Z